Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

The human noncoding genome defined by genetic diversity.

di Iulio J, Bartha I, Wong EHM, Yu HC, Lavrenko V, Yang D, Jung I, Hicks MA, Shah N, Kirkness EF, Fabani MM, Biggs WH, Ren B, Venter JC, Telenti A.

Nat Genet. 2018 Mar;50(3):333-337. doi: 10.1038/s41588-018-0062-7. Epub 2018 Feb 26.

PMID:
29483654
2.

Deep sequencing of 10,000 human genomes.

Telenti A, Pierce LC, Biggs WH, di Iulio J, Wong EH, Fabani MM, Kirkness EF, Moustafa A, Shah N, Xie C, Brewerton SC, Bulsara N, Garner C, Metzker G, Sandoval E, Perkins BA, Och FJ, Turpaz Y, Venter JC.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11901-11906. Epub 2016 Oct 4.

3.

Library preparation methodology can influence genomic and functional predictions in human microbiome research.

Jones MB, Highlander SK, Anderson EL, Li W, Dayrit M, Klitgord N, Fabani MM, Seguritan V, Green J, Pride DT, Yooseph S, Biggs W, Nelson KE, Venter JC.

Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):14024-9. doi: 10.1073/pnas.1519288112. Epub 2015 Oct 28.

4.

Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs.

Torres AG, Fabani MM, Vigorito E, Williams D, Al-Obaidi N, Wojciechowski F, Hudson RH, Seitz O, Gait MJ.

Nucleic Acids Res. 2012 Mar;40(5):2152-67. doi: 10.1093/nar/gkr885. Epub 2011 Nov 8.

5.

Site-selective artificial ribonucleases: oligonucleotide conjugates containing multiple imidazole residues in the catalytic domain.

Beloglazova NG, Fabani MM, Polushin NN, Sil'nikov VV, Vlassov VV, Bichenkova EV, Zenkova MA.

J Nucleic Acids. 2011;2011:748632. doi: 10.4061/2011/748632. Epub 2011 Sep 25.

6.

MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection.

Torres AG, Fabani MM, Vigorito E, Gait MJ.

RNA. 2011 May;17(5):933-43. doi: 10.1261/rna.2533811. Epub 2011 Mar 25.

7.

Efficient inhibition of miR-155 function in vivo by peptide nucleic acids.

Fabani MM, Abreu-Goodger C, Williams D, Lyons PA, Torres AG, Smith KG, Enright AJ, Gait MJ, Vigorito E.

Nucleic Acids Res. 2010 Jul;38(13):4466-75. doi: 10.1093/nar/gkq160. Epub 2010 Mar 11.

8.

PNA-peptide conjugates as intracellular gene control agents.

Ivanova GD, Fabani MM, Arzumanov AA, Abes R, Yin H, Lebleu B, Wood M, Gait MJ.

Nucleic Acids Symp Ser (Oxf). 2008;(52):31-2. doi: 10.1093/nass/nrn016.

PMID:
18776238
9.
10.

RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.

Turner JJ, Jones S, Fabani MM, Ivanova G, Arzumanov AA, Gait MJ.

Blood Cells Mol Dis. 2007 Jan-Feb;38(1):1-7. Epub 2006 Nov 17. Review.

PMID:
17113327
11.

Oligonucleotide analogs as antiviral agents.

Fabani MM, Turner JJ, Gait MJ.

Curr Opin Mol Ther. 2006 Apr;8(2):108-14. Review.

PMID:
16610762
12.

Sequence-specific artificial ribonucleases. I. Bis-imidazole-containing oligonucleotide conjugates prepared using precursor-based strategy.

Beloglazova NG, Fabani MM, Zenkova MA, Bichenkova EV, Polushin NN, Sil'nikov VV, Douglas KT, Vlassov VV.

Nucleic Acids Res. 2004 Jul 23;32(13):3887-97. Print 2004.

13.

Study of in vitro stability of liposomes and in vivo antibody response to antigen associated with liposomes containing GM1 after oral and subcutaneous immunization.

Fabani MM, Gargini R, Taira MC, Iacono R, Alonso-Romanowski S.

J Liposome Res. 2002 Feb-May;12(1-2):13-27.

PMID:
12604034

Supplemental Content

Loading ...
Support Center